Volume 2, Issue 1, March 2023

View Volume 2, Issue 1, March 2023

Frontline management of transplant-ineligible newly diagnosed multiple myeloma (TINDMM) in Canada
Controversies and current practices in CNS relapse of diffuse large B-cell lymphoma
Management of limited stage Hodgkin lymphoma
Tyrosine kinase inhibitors for the frontline management of CML: An overview
Venetoclax-based lower-intensity regimens for acute myeloid leukemia: Clinical pearls for a new standard of care

Published: 2023-03-01

Articles

Frontline management of transplant-ineligible newly diagnosed multiple myeloma (TINDMM) in Canada

Christopher Venner, MD, FRCPC, Julia Varghese, MD, FRCPC

5–9
- PDF (en)
- PDF (fr)
Controversies and current practices in CNS relapse of diffuse large B-cell lymphoma

Robert Puckrin, MD, FRCPC, Douglas A. Stewart, MD, FRCPC

11–14
- PDF (en)
- PDF (fr)
Management of limited stage Hodgkin lymphoma

Shruthi Kodad, DNB, FHO

16–20
- PDF (en)
- PDF (fr)
Tyrosine kinase inhibitors for the frontline management of CML: an overview

Dennis Dong Hwan Kim, MD, PhD

22–26
- PDF (en)
- PDF (fr)
Venetoclax-based lower-intensity regimens for acute myeloid leukemia Clinical pearls for a new standard of care

Guillaume Richard-Carpentier, MD, FRCPC

28–33
- PDF (en)
- PDF (fr)